Analysis of blood NAD+ pathway metabolites in healthy subjects

Analysis of blood NAD+ pathway metabolites in healthy subjects - N/A

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041232

Enrollment

Registered

2020-07-28

Start date

2020-07-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Meal control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Healthy adults *Health means a person who has not taken regular medication and has not been hospitalized. 2. Those who agree to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Those who take supplements containing vitamin B3 and wish to continue during the trial. 2. Those who are potentially pregnant. 3. Those who are under lactation. 4. Those who are under treatment. 5. Those judged by doctors or researchers to be inappropriate to participation in research.

Design outcomes

Primary

Measure	Time frame
Quantification of blood NAD+ value and comparison of blood concentration between morning and night	—

Secondary

Measure	Time frame
Comparison of blood concentrations of metabolites detected by mass spectrometry between morning and evening	—

Countries

Japan

Contacts

Public ContactTakashi Ito

RIKEN Center for Sustainable Resource Science

takashi.ito.cj@riken.jp048-467-9518

Outcome results